Overview

NYC Hep B Patients for a Cure Committee Goal

Working towards a cure for HBV infection through collective action

Purpose

The Committee will provide advice to drug/medical diagnostics developers on issues related to clinical development of investigational and marketed drugs/diagnostics and their use by patients with chronic HBV infection.

The Committee may consider topics such as:

• Patient-centric clinical trial design
• Patient preference study design
• Benefit-risk determinations
• Unmet medical needs
• Patient reported outcomes or health status issues
• Other patient related topics

Proposed Next Steps

• Contact Henry if you are interested to join and serve on the Committee
• The Committee will convene its first meeting in July 2017
• Working with community partners, organize and host a citywide workshop on “Ending the Hep B Epidemic” with an official kick-off for the Committee (4Q17)
• Invite HBV drug developers to review and provide patient-centric inputs on issues related to clinical trial strategies, protocols, and designs